Dashenlin Pharmaceutical Group Co., Ltd. Class ASSE: 603233

(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Indicative Announcement on Suspension of Conversion of "DaShenLin Convertible Bonds" During the Implementation of Dividend Distribution for the First Half of 2026

· Issued by Dashenlin Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange

Filed with SSE · Stock code 603233 ·

Indicative Announcement on Suspension of Conversion of "DaShenLin Convertible Bonds" During the Implementation of Dividend Distribution for the First Half of 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

View original source (Shanghai Stock Exchange)Company analysis

Earlier from Dashenlin Pharmaceutical Group Co., Ltd. Class A

All Dashenlin Pharmaceutical Group Co., Ltd. Class A news releases